Clinical Trial Update: A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for SYM-1219 in bacterial vaginosis has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• SYM-1219

Snippet

Sponsor: Symbiomix Therapeutics | Conditions: Bacterial Vaginosis | Phase 2 | Status: COMPLETED | Results posted: 2017-12-14